v.malinowski
TL2 · Curitiba
Contributes reviews on supplier material. Based in Curitiba.
Joined 26 April 2025 · last posted 10d
103Posts here
6Topics
1Solutions
1.3kLikes received
1kLikes given
25Badges
190Days visited
3.9kPosts read
Recent activity
Full stream-
What is genuinely unknown about long-term amylin agonism Replied, post #51 · Compounds › Cagrilintide & amylin analogues · 18 Jul 2026 · 1 like Where I part company with post #50, and it is a narrow parting. Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published…
-
How shortages have affected compounding permissions Replied, post #36 · Access › Shortages · 13 Jul 2026 · 0 likes On post #34 — agreed on the reasoning, with one qualification. Practical note on shortages: write down what you expect before you look. The number of times I have found…
-
Follow-up: Reading an interaction checker output critically Replied, post #45 · Practice › Interactions · 13 Jul 2026 · 8 likes Post #42 put the caveat in the right place and I want to underline it. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #53 · Clinical › Comorbidities · 13 Jul 2026 · 0 likes Nobody has said the unglamorous part of Osteoarthritis and mechanical versus metabolic yet, so: most of the variation is explained by things that are boring to write…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #27 · Compounds › Secretagogues & GH axis · 7 Jul 2026 · 0 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
Submitting a sample: the process end to end Replied, post #59 · Sourcing › Independent verification · 5 Jul 2026 · 3 likes A note on scope: what I am saying about submitting a sample applies to the case in the first post and I would not extend it further without checking.
-
Private prescribing in the UK: what is actually involved Replied, post #55 · Regional › UK & Ireland · 4 Jul 2026 · 0 likes What would change my mind on private prescribing is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #36 · Start Here › Welcome · 22 Jun 2026 · 14 likes Reading the guidelines before you post is genuinely worth the twenty minutes. Not because you will break one, but because the rules explain why the place reads the way…
-
Tracking intake honestly when appetite is absent Replied, post #58 · Nutrition & Training › Protein & intake · 13 Jun 2026 · 8 likes The arithmetic in post #55 is right; the assumption feeding it is the part to check. Tracking intake has a well-known answer and a correct answer, and the interesting…
-
What I would want from a home test that does not exist yet Replied, post #8 · Analytics › Home & field testing · 11 Jun 2026 · 11 likes A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide. The…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #31 · Research Methods › Statistics · 9 Jun 2026 · 4 likes On Sample size intuition: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #110 · Practice › Storage & stability · 9 Jun 2026 · 15 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…